22 February 2002
The course of vision disturbances in a patient with the MELAS syndrome.
Maria Formińska-Kapuścik, Henryk Kurzbauer, Jan Talar, Salvatore DiMauro, Maria Pachalska, Bruce Duncan MacQueen, Iwona Pawlicka, Irena Jeleńska-SzygułaMed Sci Monit 2002; 8(2): CS11-20 :: ID: 420927
Abstract
BACKGROUND: This article describes the neuropsychological and ophthalmicsymptoms presented by a patient with MELAS, a mitochondrial cytopathy. This rare disease is characterizedby a remitting-relapsing course against the background of a slowly progressive degenerative process.CASE REPORT: The patient is a 22-year-old Polish female, with initial onset of symptoms in 1994; theclinical diagnosis of MELAS was established in 1998, and confirmed in 2000 by the discovery of a novelmtDNA mutation. Her visual acuity fluctuates from near-normal to near-blindness, often changing dramaticallywithin a matter of weeks; the visual field has more or less steadily narrowed to lunate. Visual evokedpotentials show sporadic disturbances, while the nerve fiber layer shows significant attenuation. Theevidence points to a complex etiology, involving both cortical damage and attenuation of the optic nervesand neural pathways. A similar two-phase pattern--episodic disturbances with rapid spontaneous recoveryagainst a background of progressive deterioration--occurs in neuropsychological testing, which revealsprogressive dementia and episodic aphasia. CONCLUSIONS: The peculiar pathomechanism of MELAS resultsin simultaneous insults to various parts of the central and peripheral nervous systems, creating thecomplex and highly variable pattern seen in this patient. In clinical practice care should be taken notto overlook the possible significance of such a pattern appearing in various systems and on varying levels.
Keywords: MELAS syndrome, Magnetic Resonance Imaging, Vision Disorders, Vision Tests
472 4
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952